GlassScriptPhysician profile
Jeffrey S Freyder
NPI 1174813026
$1,762.63
in general payments reported to CMS, 2019-2025
12 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2021: $370 · 2022: $296 · 2023: $230 · 2024: $446 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $492.70 | 2021-2025 | Na, Actis, Monovisc |
| Smith+Nephew, INC. | $278.65 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Rattan and Associates | $239.35 | 2024 | |
| Stryker Corporation | $206.96 | 2021-2022 | |
| Vericel Corporation | $141.67 | 2019-2023 | Maci |
| Argentum Medical | $124.84 | 2021 | |
| Innovation Technologies INC | $123.29 | 2022 | |
| Zimmer Biomet Holdings, INC. | $85.34 | 2021 | |
| Bioventus LLC | $25.86 | 2023 | Gelsyn-3 |
| Boston Scientific Corporation | $16.57 | 2023 | Watchman Flx |
| Orthofix Medical, INC. | $14.75 | 2025 | Physio-Stim |
| Biocomposites INC | $12.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Freyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.